Cellink targets lab-on-a-chip applications with Nanoscribe acquisition
25 May 2021
Swedish bio-printing pioneer says it will gain a âleg upâ on competition with cash-plus-stock deal worth up to â¬50M.
Nanoscribe, the spin-out from the Karlsruhe Institute of Technology (KIT) that developed two-photon polymerization tools to make tiny, intricate structures, is set to become part of the fast-growing Swedish life sciences firm Cellink.
The two firms have agreed a cash-plus-stock deal that will see Cellink pay an initial â¬34 million for Nanoscribe, plus up to an additional â¬16 million in earn-outs if financial targets are met.
Assuming that the acquisition proceeds as expected, Nanoscribe will join forces with several other recent purchases made by Cellink, as the firm looks to build a portfolio of cutting-edge technologies that it believes will revolutionize biology and healthcare.